Prestal Holdings Limited

Consumer Defensive AU PTL

0.088AUD
0.007(8.64%)

Last update at 2024-11-13T05:10:00Z

Day Range

0.080.09
LowHigh

52 Week Range

0.070.17
LowHigh

Fundamentals

  • Previous Close 0.08
  • Market Cap13.98M
  • Volume263689
  • P/E Ratio-
  • Dividend Yield24.69%
  • EBITDA2.41M
  • Revenue TTM20.92M
  • Revenue Per Share TTM0.12
  • Gross Profit TTM 52.31M
  • Diluted EPS TTM-0.12

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 7.05M 9.55M 7.68M 7.22M 2.76M
Minority interest - - - - -
Net income 4.89M 6.37M 5.36M 5.02M 1.92M
Selling general administrative 19.60M 20.27M 16.04M 15.41M 13.48M
Selling and marketing expenses 17.98M 18.44M 10.53M 11.98M 9.74M
Gross profit 53.22M 57.46M 42.06M 43.42M 34.92M
Reconciled depreciation 3.81M 3.90M 3.85M 4.58M 3.32M
Ebit 7.37M 9.70M 8.11M 7.34M 5.01M
Ebitda 11.17M 13.60M 11.95M 11.91M 8.33M
Depreciation and amortization 3.81M 3.90M 3.85M 4.58M 3.32M
Non operating income net other - - - - -
Operating income 7.37M 9.70M 8.11M 7.34M 5.01M
Other operating expenses 107.98M 106.82M 117.27M 119.16M 95.50M
Interest expense 0.32M 0.15M 0.08M 0.12M 0.07M
Tax provision 2.16M 3.18M 2.32M 2.20M 0.83M
Interest income 0.33M 0.14M 0.07M 0.14M 0.02M
Net interest income -0.36700M -0.18900M -0.12100M -0.11600M -0.07300M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.16M 3.18M 2.32M 2.20M 0.83M
Total revenue 115.26M 117.43M 124.94M 126.46M 100.45M
Total operating expenses 45.94M 46.85M 34.39M 36.11M 29.98M
Cost of revenue 62.05M 59.97M 82.88M 83.04M 65.52M
Total other income expense net 0.13M -0.15500M -0.42500M -0.11600M -2.25800M
Discontinued operations - - - - -
Net income from continuing ops 4.89M 6.37M 5.36M 5.02M 1.92M
Net income applicable to common shares 4.89M 6.37M 5.36M 5.02M 1.92M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 30.26M 98.47M 105.28M 75.59M 82.17M
Intangible assets - 22.45M 22.46M 12.18M 12.51M
Earning assets - - - - -
Other current assets 0.16M 1.66M 0.67M 0.33M 0.64M
Total liab 2.42M 26.59M 33.47M 18.85M 26.37M
Total stockholder equity 27.84M 71.88M 71.81M 56.75M 55.80M
Deferred long term liab - - - - -
Other current liab 1.53M 0.05M 12.03M 0.08M 0.21M
Common stock 73.15M 103.83M 103.83M 90.66M 90.66M
Capital stock - 103.83M 103.83M 90.66M 90.66M
Retained earnings -45.30700M -32.63200M -32.40800M -34.15900M -35.16200M
Other liab - 6.43M 5.42M 2.44M 3.00M
Good will 5.74M 18.90M 18.90M - -
Other assets - - - - -
Cash 21.80M 1.78M 8.13M 12.70M 3.67M
Cash and equivalents - - - - -
Total current liabilities 1.93M 18.37M 25.62M 15.97M 22.62M
Current deferred revenue - 6.01M - 7.69M 10.60M
Net debt -21.77100M 2.46M -3.33500M -11.72400M -2.46600M
Short term debt 0.03M 2.45M 2.37M 0.53M 0.46M
Short long term debt - 1.70M 1.70M - -
Short long term debt total 0.03M 4.24M 4.80M 0.98M 1.20M
Other stockholder equity - 0.14M 0.39M 0.25M 0.30M
Property plant equipment - 19.56M 19.90M 20.23M 21.80M
Total current assets 24.21M 37.56M 44.01M 43.18M 47.86M
Long term investments - - - - -
Net tangible assets - 30.53M 30.45M 44.57M 43.29M
Short term investments - - - - -
Net receivables 0.29M 15.47M 17.39M 14.10M 20.13M
Long term debt - 0.42M 2.12M - -
Inventory 1.97M 18.65M 17.82M 16.05M 23.42M
Accounts payable 0.37M 9.86M 11.22M 7.66M 11.35M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.68M 0.39M 0.25M 0.30M
Additional paid in capital - - - - -
Common stock total equity - - - - 90.66M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.11M - - - -
Deferred long term asset charges - - - - -
Non current assets total 6.05M 60.91M 61.27M 32.41M 34.31M
Capital lease obligations - 2.12M 0.97M 0.98M 1.20M
Long term debt total - 1.79M 2.43M 0.45M 0.75M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments - -5.02000M -22.89600M -1.95500M -2.07900M
Change to liabilities - -3.17400M 0.62M -6.04900M 1.32M
Total cashflows from investing activities - -5.02000M -22.89600M -1.95500M -2.07900M
Net borrowings - -2.59500M 2.97M -0.69600M -0.27900M
Total cash from financing activities -45.18300M -7.70900M 8.40M -5.05600M -3.00400M
Change to operating activities - -0.54700M -0.16500M 0.41M 0.13M
Net income -20.61400M 4.89M 6.37M 5.36M 5.02M
Change in cash 20.01M -6.34800M -4.57000M 9.03M 3.42M
Begin period cash flow 1.78M 8.13M 12.70M 3.67M 0.25M
End period cash flow 21.80M 1.78M 8.13M 12.70M 3.67M
Total cash from operating activities 11.53M 6.38M 10.27M 16.05M 8.51M
Issuance of capital stock - - 10.47M - -
Depreciation 0.34M 3.69M 3.90M 3.85M 4.58M
Other cashflows from investing activities - -3.53700M -20.65400M - -
Dividends paid 42.62M 5.11M 4.62M 4.36M 2.73M
Change to inventory 6.63M -0.83000M 0.86M 7.37M -0.64200M
Change to account receivables 15.18M 1.93M -1.54800M 6.04M -2.51600M
Sale purchase of stock -30.68300M 0.00000M -0.42000M - -
Other cashflows from financing activities -0.05400M -0.89500M 7.65M -0.69600M -0.27900M
Change to netincome - 0.17M 1.22M 0.48M 0.07M
Capital expenditures 0.28M 1.48M 2.24M 1.96M 2.08M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 9.54M -1.96000M -1.56200M 6.35M -1.15600M
Stock based compensation - 0.17M 0.17M 0.14M 0.07M
Other non cash items 32.48M 9.86M -10.26600M -9.21200M -9.59500M
Free cash flow 11.25M -1.48300M 8.02M -1.95500M -2.07900M

Peer Comparison

Sector: Consumer Defensive Industry: Household & Personal Products

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PTL
Prestal Holdings Limited
0.007 8.64% 0.09 - - 0.67 0.50 0.52 5.04
MCP
Mcpherson'S Ltd
0.02 5.26% 0.40 - 16.08 0.39 0.63 0.35 16.32
S66
Star Combo Pharma Ltd
- -% 0.11 - - 0.67 0.53 0.49 6.14
ZNO
Zoono Group Ltd
-0.002 7.41% 0.03 - - 8.81 1.48 8.51 -1.3808
AN1
Anagenics Ltd
- -% 0.008 - - 0.34 1.36 0.26 -3.9793

Reports Covered

Stock Research & News

Profile

Prestal Holdings Limited manufactures, markets, and distributes household chemical, cleaning products, and gift hampers in Australia. It offers soap; stain remover; fabric care, conditioner, and solution; firelighters; gift packs; household products; bathroom; bleach; dishwashing; laundry; toilet; personal care; hand sanitizer; hand wash; and toothpaste. The company engages in e-commerce gifting business. It sells its products under the pental, AIM, Country Life, Duracell, Huggie, Janola, Jiffy, Little Lucifer, LUX, Martha's, Procell, Softly, Sunlight, Velvet, and White King brands. The company was formerly known as Pental Limited and changed its name to Prestal Holdings Limited in November 2023. The company was founded in 1856 and is headquartered in Melbourne, Australia.

Prestal Holdings Limited

390 St Kilda Road, Melbourne, VIC, Australia, 3004

Key Executives

Name Title Year Born
Mr. Charlie McLeish MD, CEO & Director NA
Mr. Neil Godara Chief Financial Officer NA
Mr. Oliver Carton BJuris, L.L.B., LLB Company Sec. 1964
Mr. Charles McLeish MD, CEO & Director NA
Mr. Oliver Carton BJuris, L.L.B., LLB Company Secretary 1964
Mr. Charles McLeish MD, CEO & Director NA
Mr. Oliver Carton BJuris, L.L.B., LLB Company Secretary 1964
Mr. Charles McLeish MD, CEO & Director NA
Mr. Oliver Carton BJuris, L.L.B., LLB Company Secretary 1964
Mr. Charles McLeish MD, CEO & Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.